Related Experiment Video
Updated: Jul 9, 2026
07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
Cholesterol screening in an at-risk pediatric population
Michael Joseph O'Grady1, Anne-Marie Brown, Michael Brendan O'Neill
1Department of Paediatrics, Mayo General Hospital, Castlebar, Ireland. michael_ogrady2001@hotmail.com
Pediatric Cardiology
|December 21, 2007
Summary
High LDL cholesterol is common in children with a family history of early heart disease. Early screening and dietary advice are crucial for these pediatric patients to prevent future cardiovascular issues.
Area of Science:
- Pediatric Cardiology
- Preventive Cardiology
- Lipid Metabolism
Background:
- Elevated low-density lipoprotein (LDL) cholesterol in childhood is a significant risk factor for premature atherosclerosis.
- Family history of premature ischemic heart disease (before age 55) indicates increased genetic predisposition.
- Pediatric hypercholesterolemia often has its origins in childhood and adolescence.
Purpose of the Study:
- To determine the frequency of elevated LDL cholesterol in children and adolescents with a parental history of premature ischemic heart disease.
- To assess the need for early screening and intervention in at-risk pediatric populations.
- To provide data supporting the American Academy of Pediatrics (AAP) guidelines for lipid screening.
Main Methods:
- A cohort of children and adolescents (8-18 years) with at least one parent having premature ischemic heart disease was recruited.
- Fasting lipid profiles were obtained for eligible participants.
- Results were categorized as normal, borderline/high, or high based on AAP guidelines.
Main Results:
- Out of 82 children screened, 8.5% (7/82) had high LDL cholesterol levels.
- An additional 20.7% (17/82) exhibited borderline/high LDL cholesterol.
- These findings highlight a substantial prevalence of dyslipidemia in this high-risk pediatric group.
Conclusions:
- Screening for hypercholesterolemia in children with a family history of early heart disease is highly recommended.
- Early identification and intervention, including dietary advice, are essential for managing pediatric lipid disorders.
- Proactive management in pediatric patients can mitigate the risk of developing atherosclerosis and future cardiovascular events.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...